Sun Pharma launches cheapest favipiravir brand in India, at Rs 35 a pill

Pricing pressure in this category is already visible as Glenmark revised its original price (Rs 103 per tablet) to Rs 79 per tablet within a month of the launch

Joining the long list of firms to launch its own brand of oral antiviral drug favipiravir, the country's largest drugmaker Sun Pharmaceutical Industries on Tuesday launched the cheapest brand of favipiravir in the market - FluGuard. 

Priced at Rs 35 a tablet this will be the cheapest brand available so far. Jenburkt Pharma's brand Favivent is priced at Rs 39 per tablet. 

Favipiravir is used for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.

Kirti Ganorkar,